You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API eplontersen


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing eplontersen

Company Tradename Ingredient NDC Excipient Potential Generic Entry
AstraZeneca Pharmaceuticals LP WAINUA eplontersen 0310-9400 HYDROCHLORIC ACID 2030-12-21
AstraZeneca Pharmaceuticals LP WAINUA eplontersen 0310-9400 SODIUM CHLORIDE 2030-12-21
AstraZeneca Pharmaceuticals LP WAINUA eplontersen 0310-9400 SODIUM HYDROXIDE 2030-12-21
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Detailed excipient profiles for eplontersen

Excipient focus: HYDROCHLORIC ACID

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.